EORTC QLQ-30
Sponsors
Washington University School of Medicine, Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Conditions
Head and Neck Squamous Cell CarcinomaStage III Solid TumorsStage IV Solid Tumors
Phase 1
Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Active, not recruitingNCT03650764
Start: 2019-05-29End: 2026-06-30Updated: 2025-12-30
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
TerminatedNCT03655444
Start: 2019-05-29End: 2020-08-24Updated: 2020-12-03
Unknown Phase
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (DINOSAur)
NCT05692466
Start: 2023-02-01End: 2025-11-01Target: 572Updated: 2023-03-03
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting (DINOSAur II)
NCT05703243
Start: 2023-02-01End: 2025-01-01Target: 572Updated: 2023-03-03